129 related articles for article (PubMed ID: 17199960)
1. Natural history of benign prostate hyperplasia.
Wu SL; Li NC; Xiao YX; Jin J; Qiu SP; Ye ZQ; Kong CZ; Sun G; Na YQ
Chin Med J (Engl); 2006 Dec; 119(24):2085-9. PubMed ID: 17199960
[TBL] [Abstract][Full Text] [Related]
2. [Study on patients with benign prostate hyperplasia treated by the therapeutic regimen of watchful waiting during a twenty-four-month follow-up period].
Zhang YG; Wang JY; Liu M; Xu J; Wu JY; Xin Y; Wan B; Wei D; Zhu SC; Zeng P
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):611-3. PubMed ID: 19040049
[TBL] [Abstract][Full Text] [Related]
3. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
[TBL] [Abstract][Full Text] [Related]
4. [Data analysis of the objective observation parameters of benign prostatic hyperplasia patients accepting different treatment regimens].
Zhang YG; Wang JY; Liu M; Wan B; Wei D; Deng SM; Xu J; Wu JY; Chu X; Zeng P
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1690-2. PubMed ID: 19024540
[TBL] [Abstract][Full Text] [Related]
5. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia.
Agrawal CS; Chalise PR; Bhandari BB
Nepal Med Coll J; 2008 Jun; 10(2):104-7. PubMed ID: 18828432
[TBL] [Abstract][Full Text] [Related]
6. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
7. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
9. Watchful waiting in benign prostatic hyperplasia.
Wiygul J; Babayan RK
Curr Opin Urol; 2009 Jan; 19(1):3-6. PubMed ID: 19057209
[TBL] [Abstract][Full Text] [Related]
10. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
11. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
12. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
Chalise PR; Agrawal CS
Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
O'Leary MP; Wei JT; Roehrborn CG; Miner M;
BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
[TBL] [Abstract][Full Text] [Related]
14. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
[TBL] [Abstract][Full Text] [Related]
15. [Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters].
Zhao Z; Wang G; Na YQ
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):957-9. PubMed ID: 17961379
[TBL] [Abstract][Full Text] [Related]
16. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
McVary KT; Roehrborn CG; Kaminetsky JC; Auerbach SM; Wachs B; Young JM; Esler A; Sides GD; Denes BS
J Urol; 2007 Apr; 177(4):1401-7. PubMed ID: 17382741
[TBL] [Abstract][Full Text] [Related]
17. [Effect of transurethral resection of prostate on quality of life in aged patients with benign prostatic hyperplasia].
Cheng NZ; Tang ZY; Liu Y; Liu XS; Qi L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):975-8. PubMed ID: 19001744
[TBL] [Abstract][Full Text] [Related]
18. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
Sakr M; Eid A; Shoukry M; Fayed A
Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
[TBL] [Abstract][Full Text] [Related]
19. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
20. [Electroacupuncture at Zhongji (CV 3) for treatment of benign hyperplasia of prostate: a multi-central randomized controlled study].
Liu QG; Wang CY; Jiao S; Tang LX; Peng MH; Tian LF; Ding WX; Zhao X; Lu SK; Fu YJ; Tan WL; Qin Y
Zhongguo Zhen Jiu; 2008 Aug; 28(8):555-9. PubMed ID: 18767576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
